Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1996;3(2):63–66. doi: 10.1155/MBD.1996.63

Anti-Tumor Activity, In Vitro and In Vivo, of Some Triphenylphosphinegold(I) Thionucleobases

Lorraine K Webster 1,, Silvina Rainone 1, Ernst Horn 2, Edward R T Tiekink 2,
PMCID: PMC2365007  PMID: 18472797

Abstract

The [Ph3PAu(6-MP)] complex, where 6-MPH is 6-mercaptopurine, is active against the cisplatinresistant cell line, mouse leukaemia L1210/DDP, as is the precursor compound [Ph3PAuCl], suggesting that the thiolate is not critical for activity. Against the human cell lines, FaDu (squamous cell carcinoma) and SKOV-3 (ovarian carcinoma), both [Ph3PAu(6-MP)] and [Ph3PAu(6-TG)], where 6-TGH is 6-thioguanine, were active. [Ph3PAu(6-MP)] was active against a murine PC6 plasmacytoma, but not as active as cisplatin.

Full Text

The Full Text of this article is available as a PDF (540.9 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES